voriconazole

Ukraine

Drugs containing this active substance

  • KANDIVOR

    The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by species of Candida, Scedosporium, and Fusarium. It is also used for the prevention of fungal infections in patients following stem cell transplantation.

    Form: powder for solution for infusion

    Active substance Dosage
    voriconazole 200 mg

    ATC: J02AC03

    Manufacturer: Aspiron Pharma Limited

  • The drug is used for the prevention of invasive fungal infections during allogeneic bone marrow transplantation, as well as for the treatment of invasive aspergillosis, candidemia, and severe infections caused by Candida species (including those resistant to fluconazole), Scedosporium, and Fusarium.

    Form: powder for solution for infusion

    Active substance Dosage
    voriconazole 200 mg

    ATC: J02AC03

    Manufacturer: Yuria-Pharm LLC, Ukraine (packaging of bulk products from manufacturer Anfarm Hellas S.A., Greece)

  • The drug is used to treat invasive aspergillosis, candidemia, as well as severe fungal infections caused by Scedosporium and Fusarium species. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.

    Form: powder for solution for infusion

    Active substance Dosage
    voriconazole 200 mg

    ATC: J02AC03

    Manufacturer: Intas Pharmaceuticals Limited (manufacturing of medicinal product, primary and secondary packaging, quality control of batch)

  • The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Scedosporium and Fusarium species. It is also used for the prevention of fungal infections in patients following bone marrow transplantation.

    Form: powder for solution for infusion

    Active substance Dosage
    voriconazole 200 mg

    ATC: J02AC03

    Manufacturer: Hainan Poly Pharma Co., Ltd.

  • The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by species of Candida, Scedosporium, and Fusarium. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.

    Form: lyophilisate for concentrate for infusion solution

    Active substance Dosage
    voriconazole 200 mg

    ATC: J02AC03

    Manufacturer: K.T. Rompharm Company S.R.L. (manufacturing and primary packaging of medicinal product; secondary packaging, quality control and batch release)

  • It is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Candida, Scedosporium, and Fusarium species. The drug is also prescribed for the prevention of invasive fungal infections in patients following bone marrow transplantation.

    Form: powder for solution for infusion

    Active substance Dosage
    voriconazole 200 mg

    ATC: J02AC03

    Manufacturer: Farmaten S.A. (secondary packaging, batch control, responsible for batch release)

  • The drug is used to treat invasive aspergillosis, candidemia (a blood infection caused by Candida fungi), as well as severe fungal infections caused by Scedosporium and Fusarium species. It is also used for the prevention of fungal infections in patients following bone marrow transplantation.

    Form: tablets, film-coated

    Active substance Dosage
    voriconazole 50 mg

    ATC: J02AC03

    Manufacturer: Farmaten S.A. (primary and secondary packaging, batch control, responsible for batch release)

  • The drug is used to treat invasive aspergillosis, candidemia (blood infection), severe fungal infections caused by Scedosporium and Fusarium species, as well as for the prevention of fungal infections in patients after bone marrow transplantation.

    Form: tablets, film-coated

    Active substance Dosage
    voriconazole 200 mg

    ATC: J02AC03

    Manufacturer: Farmaten S.A. (primary and secondary packaging, batch control, responsible for batch release)

  • The drug is used to treat invasive aspergillosis, candidemia, as well as severe fungal infections caused by Candida species (including those resistant to fluconazole), Scedosporium, and Fusarium. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.

    Form: tablets, film-coated

    Active substance Dosage
    voriconazole 50 mg

    ATC: J02AC03

    Manufacturer: Synthon Hispania, S.L. (batch release)

  • The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Candida, Scedosporium, and Fusarium species. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.

    Form: tablets, film-coated

    Active substance Dosage
    voriconazole 200 mg

    ATC: J02AC03

    Manufacturer: Synthon Hispania, S.L. (batch release)

  • The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Scedosporium and Fusarium species. It is also used for the prevention of fungal infections in patients following bone marrow transplantation.

    Form: powder for solution for infusion

    Active substance Dosage
    voriconazole 200 mg

    ATC: J02AC03

    Manufacturer: ANFARM HELLAS S.A. (manufacturing of finished dosage form, primary and secondary packaging, batch control, batch release)

  • The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Candida, Scedosporium, and Fusarium species. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.

    Form: tablets, film-coated

    Active substance Dosage
    voriconazole 200 mg

    ATC: J02AC03

    Manufacturer: Evertoxgen Life Sciences Limited

  • The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Scedosporium and Fusarium species. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.

    Form: tablets, film-coated

    Active substance Dosage
    voriconazole 50 mg

    ATC: J02AC03

    Manufacturer: Evertoxgen Life Sciences Limited